R. Rotem-Yehudar, E. Galperin ,.M. Horowitz. Association of insulin like growth factor 1 receptor with EHD1 and SNAP29. J. Biol. Chem. Vol. 276, 2001 (pp.33054-33060)
E. Hazkani-Covo, N. Altman, M. Horowitz, D. Grauer. The evolutionary history of prosaposin: two successive tandem-duplication events gave rise to the four saposin domains in vertebrates. J. Mol. Evol. Vol. 54, 2002 (pp.30-34).
E. Galperin, S. Benjamin, D. Rapaport, R. Rotem-Yehudar, M. Horowitz. EHD3 - a protein that resides in recycling vesicular and tubular membrane structures and interacts with EHD1. Traffic. Vol. 3, 2002 (pp. 575-89).
K. Hodanova, Z. Malkova, M. Horowitz, M. Hrebicek. Transient expression of wild-type and mutant glucocerebrosidases in hybrid vaccinia expression system. Eur J Hum Genet. Vol. 11, 2003 (pp. 369-374).
A.H. Futerman, J.L. Sussman, M. Horowitz, I. Silman, A. Zimran. New directions in the treatment of Gaucher disease. Trends in Pharmacological Science, Vol. 25, 2004 (pp. 147-151).
T. Cohen, L. Ravid, N. Altman, L. Madar-Shapiro, A. Fein, M. Weil, M. Horowitz. Conservation of expression and alternative splicing in the prosaposin gene, Molecular Brain Research Vol. 129, 2004 (pp. 8-19).
T. Cohen, W. Auerbach, L. Ravid, J. Bodennec, A. Fein, A.H. Futerman, A.L. Joyner, M. Horowitz. The exon 8 containing prosaposin splice variant is dispensable for mouse development, lysosomal function and secretion. Mol. Cell. Biol. Vol. 25, 2005 (pp. 2431-2440).
I. Ron, A. Dagan, S. Gatt, M. Pasmanik-Chor, M. Horowitz. Use of fluorescent substrates for characterization of Gaucher disease mutations. Blood Cells Mol Dis. 2005 35 (pp. 57-65).
E. Sprecher, A. Ishida-Yamamoto, M. Mizrahi-Koren, D. Rapaport, D. Golsher, M. Indelman, O. Topaz, I. Chefetz, H. Keren, T.J. O’Brien, D. Bercovich, S. Shalev, D. Geiger, R. Bergman, M. Horowitz, H. Mandel. A mutation in SNAP29 , coding for a SNARE protein involved in intracellular trafficking, causes a novel neurocutaneous syndrome characterized by cerebral dysgenesis, neuropathy, ichtyosis and palmoplantar keratoderma. Am J Hum Genet. 2005 77 (pp. 242-251).
I. Ron, M. Horowitz. ER retention and degradation as the molecular mechanism underlying Gaucher disease heterogeneity. Hum. Mol. Gen. 2005 15 (pp. 2387-2398).
E. Sprecher, A. Ishida-Yamamoto, M. Mizrahi-Koren, D. Rapaport, D. Golsher, M. Indelman, O. Topaz, I. Chefetz, H. Keren, T.J. O’Brien, D. Bercovich, S. Shalev, D. Geiger, R. Bergman, M. Horowitz, H. Mandel. A mutation in SNAP29 , coding for a SNARE protein involved in intracellular trafficking, causes a novel neurocutaneous syndrome characterized by cerebral dysgenesis, neuropathy, ichtyosis and palmoplantar keratoderma. Am J Hum Genet. 2005 77 (pp. 242-251).
D. Rapaport, W. Auerbach, N. Naslavsky, M. Pasmanik-Chor, E. Galperin, E. Fein, S. Kaplan, A. Joyner, M. Horowitz. Recycling to the plasma membrane is attenuated in EHD1 knockout mice. Traffic 2006 7 (pp 52-60).
Mandel H, Sprecher E, Rapaport D, Horowitz M. SNAP29 and cerebral dysgenesis, neuropathy, ichthyosis and palmoplantar keratoderma syndrome. In: Inborn Errors of Development. CJ Epstein, RP Erickson, A Wynshaw-Boris (Eds), Oxford University Press, New York (in press).
Patents
EH domain containing genes and proteins. USA Patent no. 6,552,177.
PCT/IL2005/000530 filed 24/05/2005 Title: Methods and kits for diagnosis and/or assessing severity and treatment of Gaucher disease.